You're on the right track, so keep the approach: matching the top of each page to its ad is right for people coming from Meta, and your lab proof is something no competitor can show.
Two things hold every page back: someone who's never heard of sulforaphane sees a price and a plan picker before learning why they'd want BROQ, and there's no star rating or review count.
Fix those two once, in the part below the headline that all the pages share, and every ad gets the benefit.
What: Right under the headline, above the plan picker, add a short block with three parts. First, one plain line on what sulforaphane does in your body. Then the six benefits, each with one real study result (all already on the science page), plus the science page's "when you'll notice it" line for BROQ. Then BROQ's big numbers in one strip: 3,000+ published studies, 25 mg a serving when 11 of the top 20 competitors deliver under 1 mg, and as much as 3.5 pounds of raw broccoli. Keep it short: only what makes people want to buy, as you asked on the blood test page. On a phone, move the line that explains sulforaphane above the pack picture, so it's on the first screen. Start with the two BROQ pages for newcomers (longevity-secret, winter-ready) and the BROQ product page, then do the same on the NMN-99 and SPMD-99 pages. Judge it on sales per visitor over two full weeks.
Why: It's also how Mitopure makes people feel it's special, and all ten members raised it.
What: Install a reviews app on opus.life, bring in BROQ's real reviews, and show the rating and count right under the headline on every BROQ page and the BROQ product page, with 3 or 4 real review quotes next to Add to cart. Which number goes up is your and Nick's call (question 1).
Why: 9 of 10 members call it urgent, and the few real tests found about 5% to 15% more sales.
What: Find where Ian's (BROQ), Alvin's (NMN-99) and Diana's (SPMD-99) review pictures came from. Take down any we can't trace to a real buyer.
Why: Nothing in our files shows where these three came from, and apart from 4 and 2 ratings on Amazon, our files show no NMN-99 or SPMD-99 reviews yet. You may already know (question 2).
What: Email past buyers a few open questions (what did you hope it would do, what almost stopped you, how would you describe it to a friend), and copy the exact words from BROQ's TikTok Shop and Amazon reviews into one sheet. Then watch 3 to 5 people who've never heard of sulforaphane see the BROQ ad, then the page, on their phone, saying out loud what they think.
Why: And buyers' own words become the page's words. Then ship the changes together and judge them over two full weeks.
What: Label it as the two-servings-a-day option, mark it "Recommended", and for one week make it the plan that's already selected. Switch back if orders a day drop.
Why: It also fits what the pages already say: you may need more than one serving a day to reach the doses in the studies. Andrew Faris and Ezra Firestone back it.
1. Are we approaching this right? Mostly, yes. Nine members scored it 6 out of 10 and one gave 5. On their scale, 6 or 7 is normal for first-pass work. The matched headlines, the real lab proof and the plain guarantee are all right. What holds it back is the same on every page, below the headline: a price and plans come before the reasons to want it, and there are no reviews. On Wednesday (figures from tonight's brief, not yet checked against Shopify), 23 of 386 visitors added to cart, but 12 of the 20 who started checkout bought, so people are lost on the page, not at checkout.
2. Would product pages be better than matching every ad? No, not for people coming from ads (7 of 10 say keep the matched pages). Your ad pages already are product pages with a top matched to the ad, so the gap is small. Where most agree with your instinct: a new opening line doesn't need a whole new page. It can be a new headline on that angle's page, with the time going into the part all pages share (question 4).
3. BROQ, for someone who's never heard of sulforaphane? Not yet. All ten say the benefits come too late. On a phone, a newcomer sees the headline and the pack, then one short line, the price and the plan picker. "What is sulforaphane?" comes about five phone screens down, in a few short lines, and "6 ways BROQ works for you" are one-line labels.
Mitopure feels special because it leads with one big promise, stacks hard proof right under it (18 years of research, 25 human trials, 80 patents, "+39%" in a trial) and tells you when you'll feel it. BROQ already has its own version, scattered down the page: 3,000+ studies, a dose the competitors don't come close to, 3.5 pounds of broccoli in a serving, a seed partner working on this since the early 1990s, and real human results on the science page (lower A1C, less flu virus, LDL down 5 to 7%). Pull them to the top (item 1 under Do this). Five members also want you on the pages: your story, your face or your own blood results (question 5).
4. How urgent are reviews, stars and a count? Very. 9 of 10 call it urgent, and five put it at or near the top of the list. Peep Laja would still do the benefit words first, since they move people more; Rishi Rawat calls reviews table stakes and wants just 3 or 4 real snippets by the button. Both agree reviews belong on the page now. The material is real: BROQ has 4.5 stars from 340 on TikTok Shop, 4.1 from 557 on Amazon, and 4.85 from 1,211 on our own store, which you haven't cleared for the site.
5. Can we show one rating for all our products at the top? Yes, it's common: Timeline's home page shows "4.5 from 5921 reviews". All five members with a view said yes, if it says plainly that it covers all our products. Baymard adds: let a tap lead to the real reviews. Almost all our reviews are BROQ's, so on the NMN-99 and SPMD-99 pages it has to read as store-wide, not as theirs (question 3).
6. Should we add more from the science page? Yes, but more on each benefit, not more benefits. The six are plenty. What's worth bringing over is each benefit's real study result, plus BROQ's "when you'll notice it" line, placed above the plans. On each ad page, lead with the benefit that ad promised, like immunity on winter-ready. Kurt Elster alone would just move the six up and link to the science page.
7. Is there a better overall approach? Mostly no: keep this approach, but run it differently:
| Page | Product | Live ads | The ad's angle |
|---|---|---|---|
| broq-longevity-secret | BROQ | 1 image | The most studied longevity compound you've never heard of |
| broq-winter-ready | BROQ | 1 image | Get your immune system ready for fall and winter |
| broq-test-or-refund | BROQ | 1 image | See results in a blood test, or don't pay |
| broq-lab-comparison | BROQ | 2 (1 image, 1 video of you); 3 more videos planned tonight | The lab test: more than double the sulforaphane of 18 of the top 20 |
| nmn-99-proven-nmn | NMN-99 | 1 image | Uthever, the only clinically proven NMN |
| nmn-99-back-to-25 | NMN-99 | 1 image | Put your NAD+ back where it was at 25 |
| nmn-99-test-or-refund | NMN-99 | 1 image | See results in a blood test, or don't pay |
| spmd-99-six-more-years (and v1, v2, v3) | SPMD-99 | 4 (1 image, 3 videos of you) | Linked to nearly 6 years of longer life; v2 "Holy Grail" is our best seller |
| spmd-99-everyday-shield | SPMD-99 | 1 image | A shield against microplastics |
| spmd-99-fasting-benefits | SPMD-99 | 1 image | The benefits of fasting, without fasting |
| spmd-99-inner-glow | SPMD-99 | 1 image | Skin from the inside |
| spmd-99-fuller-look | SPMD-99 | 1 image | Fuller, thicker hair |
| spmd-99-pure-source | SPMD-99 | 1 image | Pure spermidine, not wheat germ |
| stack | All three | 1 video | At 59, you plan to live to 200 (top 3) |
| top-5-supplements | All three | 1 video | "Move over, Bryan Johnson" (top 5) |
| top-7-supplements | All three | 1 video | Younger at 60 than now (top 7) |
| lab-tested | All three | 0 live; 3 new videos tonight | The supplement industry's dirty secret |
| stack-results-or-refund | All three | 0 live; 1 new video tonight | See results in a blood test, or pay $0 |
That's 20 live ads on 19 pages, and none go to the product pages. Tonight's new ads are built paused (or still being built), set to go on after midnight if they pass their checks.
The committee judged the 3pm pages. After tonight's publish:
Tap an answer and it saves itself. Add a note if you like; it saves when you leave the box. The team reads them in the morning.